Aspirin: expectations and limitations

J Assoc Physicians India. 2008 May:56:317-9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Asia, Western
  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Aspirin / pharmacokinetics
  • Coronary Artery Disease / enzymology
  • Coronary Artery Disease / epidemiology*
  • Coronary Artery Disease / prevention & control*
  • Cross-Sectional Studies
  • Cyclooxygenase Inhibitors / administration & dosage*
  • Cyclooxygenase Inhibitors / adverse effects
  • Cyclooxygenase Inhibitors / pharmacokinetics
  • Developing Countries*
  • Dose-Response Relationship, Drug
  • Drug Resistance
  • Ethnicity / statistics & numerical data*
  • Humans
  • India
  • Long-Term Care
  • Platelet Activation / drug effects*
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / pharmacokinetics
  • Salicylic Acid / pharmacokinetics
  • Tablets, Enteric-Coated
  • Treatment Outcome

Substances

  • Cyclooxygenase Inhibitors
  • Platelet Aggregation Inhibitors
  • Tablets, Enteric-Coated
  • Salicylic Acid
  • Aspirin